Gotu Kola

Gotu Kola's primary bioactive pentacyclic triterpenoids—asiaticoside, madecassoside, asiatic acid, and madecassic acid—exert neuroprotective effects by inhibiting acetylcholinesterase, upregulating synaptic plasticity proteins (BDNF, pCREB, pCaMKII), and reducing amyloid-beta accumulation in neurodegeneration models. In a clinical meta-analysis of 11 randomized controlled trials and a specific trial using 750–1,000 mg/day extract over six weeks in patients with vascular cognitive impairment, Centella asiatica supplementation produced measurable improvements in MoCA-Indonesia cognitive scores compared to controls.

Origin & History

Centella asiatica is native to the wetlands and tropical regions of Southeast Asia, including India, Sri Lanka, Indonesia, and Madagascar, as well as parts of the Pacific Islands and sub-Saharan Africa. It thrives in moist, shaded environments such as riverbanks, paddy fields, and forest margins, growing as a low-creeping perennial herb at elevations up to 1,800 meters. Traditionally cultivated across South and Southeast Asia for millennia, it remains a staple in Sri Lankan and Indonesian cuisine and is commercially harvested in India, China, and Madagascar for pharmaceutical and cosmetic industries.

Historical & Cultural Context

Centella asiatica has been documented in Ayurvedic medicine for over 3,000 years under the Sanskrit name 'Mandukaparni,' where it was classified as a medhya rasayana—a rejuvenating tonic for mind and nervous system—and prescribed for enhancing intellect, longevity, and treating leprosy and skin disorders. In Traditional Chinese Medicine (TCM), it appears in classical texts as 'Ji Xue Cao' and was used to treat traumatic injuries, jaundice, urinary disorders, and febrile conditions, reflecting its perceived multi-system therapeutic versatility. In Sri Lanka, it has been consumed daily as 'Gotu Kola sambol'—a fresh herb salad mixed with onion, chili, and lime—representing one of the oldest continuously maintained ethnopharmacological food traditions in the world. The herb also features prominently in Indonesian Jamu herbal medicine, Malay traditional healing, and Pacific Island ethnomedicine, where aqueous and fresh preparations were applied topically to wounds and ulcers and consumed as teas for nervous system complaints.

Health Benefits

- **Cognitive Function and Memory**: Asiaticoside and asiatic acid inhibit acetylcholinesterase (AChE), increasing synaptic acetylcholine levels and upregulating plasticity proteins including BDNF, pCREB, and PSD95, supporting learning and memory consolidation in both animal models and small human trials.
- **Neuroprotection Against Neurodegeneration**: In PS/APP transgenic mouse models, Centella asiatica at 2.5 g/kg/day for 8 months significantly reduced amyloid-beta-40/42 accumulation, promoted amyloid-degrading enzymes neprilysin and insulin-degrading enzyme, and reversed mitochondrial deficits associated with Alzheimer's pathology.
- **Wound Healing and Dermal Repair**: Asiaticoside stimulates collagen type I synthesis, promotes fibroblast proliferation, and accelerates epithelialization; topical formulations at 0.2–1.0% concentrations are clinically used for scar management, burn repair, and post-surgical wound care.
- **Antioxidant Defense**: Triterpenoids and flavonoids (apigenin, rutin, quercetin) scavenge reactive oxygen species and upregulate endogenous antioxidant enzymes superoxide dismutase (SOD), catalase, and glutathione peroxidase, reducing measurable oxidative stress markers such as malondialdehyde (MDA) in preclinical studies.
- **Circulatory and Microvascular Support**: The triterpenic fraction (60–120 mg/day) has demonstrated improvement in transcutaneous oxygen and carbon dioxide pressure (PO2-PCO2) in patients with venous hypertensive microangiopathy, indicating enhanced peripheral microcirculation and capillary integrity.
- **Anti-Inflammatory Activity**: Madecassoside inhibits NF-κB signaling and reduces pro-inflammatory cytokine production (TNF-α, IL-1β, IL-6) in cellular and animal models, contributing to its traditional use in managing inflammatory skin conditions and systemic inflammation.
- **Skin Aging and Photoprotection**: Rosmarinic acid, chlorogenic acid, and dicaffeoyl quinic acids in aqueous extracts provide UV-induced oxidative stress protection and inhibit matrix metalloproteinases (MMPs) responsible for collagen degradation, supporting anti-aging topical applications.

How It Works

The pentacyclic triterpenoids asiaticoside and asiatic acid act as antioxidants through direct free radical scavenging and by transcriptionally upregulating antioxidant enzymes SOD, catalase, and glutathione peroxidase, thereby reducing lipid peroxidation markers such as MDA in neural tissues. Asiatic acid penetrates the blood-brain barrier (half-life 2–4 hours) and inhibits acetylcholinesterase activity, elevating cholinergic neurotransmission, while simultaneously modulating synaptic plasticity through increased expression of PSD95, phosphorylated NR1 (pNR1), pCaMKII, pPKA, pCREB, and BDNF—proteins central to long-term potentiation and memory consolidation. In amyloid-related neurodegeneration, these triterpenoids decrease caspase-3-mediated apoptosis, upregulate amyloid-degrading enzymes neprilysin and insulin-degrading enzyme, and restore mitochondrial membrane potential, collectively attenuating Aβ-40/42 plaque burden. Madecassoside and asiaticoside also stimulate TGF-β1-mediated collagen type I synthesis in dermal fibroblasts and inhibit NF-κB-driven inflammatory cascades, providing dual wound-healing and anti-inflammatory actions in peripheral tissues.

Scientific Research

The clinical evidence base for Centella asiatica is growing but remains limited in scale: a meta-analysis of 11 randomized controlled trials (including 5 trials testing Centella alone, total n=215 subjects) found cognitive benefits, but the majority of included trials were small, heterogeneous in design, and reported limited quantified effect sizes, reducing overall confidence. A specific clinical trial in vascular cognitive impairment patients using 750–1,000 mg/day of standardized extract over six weeks demonstrated improvement in MoCA-Indonesia cognitive scores, though comparator outcomes with folic acid were similarly positive, complicating attribution of benefit. For venous hypertensive microangiopathy, the triterpenic fraction (60–120 mg/day) improved objective measures of transcutaneous PO2-PCO2 and subjective symptom scores, but published reports have not uniformly specified sample sizes or conducted intention-to-treat analyses. The strongest mechanistic data remain from animal studies—including dose-response memory improvements at 100–300 mg/kg in rodents and Aβ reduction in PS/APP transgenic mice—and robust human pharmacokinetic data supporting rapid tissue distribution and BBB penetration of asiatic acid.

Clinical Summary

Clinical investigation of Gotu Kola has centered on cognitive enhancement and peripheral vascular outcomes, with the most structured evidence coming from a meta-analysis of 11 RCTs totaling approximately 215 subjects, which found statistically significant but incompletely reported cognitive improvements. The dosing range studied clinically spans 60 mg/day of triterpenic fraction for microvascular indications to 750–1,000 mg/day standardized extract for cognitive applications, with six weeks being the most common trial duration. Standardized MoCA-Indonesia scores improved in the vascular cognitive impairment trial, though folic acid controls showed similar improvement, suggesting potential non-specificity or additive confounding. Overall, confidence in results is moderate for circulatory applications and preliminary-to-moderate for cognitive outcomes, constrained by small sample sizes, short durations, lack of blinding details in some trials, and absence of large multicenter RCTs.

Nutritional Profile

Fresh Centella asiatica leaves contain approximately 2.4 g protein, 0.9 g fat, and 6.0 g carbohydrates per 100 g fresh weight, along with notable micronutrients including iron (5.6 mg/100g), potassium, calcium, magnesium, zinc, copper, manganese, cobalt, and sodium. Vitamin C and beta-carotene are present, contributing antioxidant nutritional value alongside the phytochemical matrix. Primary phytochemicals include pentacyclic triterpenoids—asiaticoside and madecassoside (C48H78O19/C48H78O20) and their aglycones asiatic acid and madecassic acid, each up to approximately 1% of dry weight—alongside anthocyanins (up to 37.6 mg/100 g), flavonoids (apigenin, rutin, quercetin), rosmarinic acid, and chlorogenic and dicaffeoyl quinic acids concentrated in aqueous extracts. Bioavailability of triterpenoids is relatively low from whole herb preparations due to glycosidic bonding, but metabolites MDA (madecassic acid) and ASA (asiatic acid) achieve higher plasma concentrations than their parent glycosides after intestinal hydrolysis, with peak distribution within 5–15 minutes post-dose for intravenous formulations; asiatic acid demonstrates confirmed blood-brain barrier penetration with a half-life of 2–4 hours.

Preparation & Dosage

- **Standardized Extract (Capsule/Tablet)**: 30–90 mg/day for general wellness; clinical trials have used 750–1,000 mg/day for cognitive support; standardized to contain 8–40% total triterpenoids (asiaticoside, madecassoside, asiatic acid, madecassic acid).
- **Crude Dried Herb (Powder or Capsule)**: 1.5–4 g/day, typically divided into two or three doses; traditional food-grade preparation consumed in Sri Lanka and Southeast Asia as fresh leaf salads or cooked vegetables.
- **Triterpenic Fraction (Pharmaceutical Grade)**: 60–120 mg/day used specifically for venous insufficiency and microangiopathy indications; this is a concentrated, purified extract formulation.
- **Aqueous Tea/Infusion**: Traditional preparation using 1–2 teaspoons dried herb steeped in 250 mL hot water for 10–15 minutes; rich in chlorogenic and dicaffeoyl quinic acids with lower triterpenoid content than hydroalcoholic extracts.
- **Topical Serum or Cream**: Concentrations of 0.2–1.0% Centella extract applied directly to skin for wound healing, scar reduction, and anti-aging; madecassoside content is the primary active component in dermal formulations.
- **Liquid Extract (Tincture)**: Hydroalcoholic extracts (1:1 to 1:5 ratio) used at 2–4 mL/day; retains broader phytochemical spectrum including flavonoids and phenolic acids.
- **Timing Note**: No established timing requirement; consistent daily dosing over a minimum of 4–8 weeks is recommended to assess cognitive or vascular outcomes based on trial durations.

Synergy & Pairings

Gotu Kola is frequently paired with Bacopa monnieri in Ayurvedic cognitive formulations, where both herbs independently inhibit acetylcholinesterase and upregulate BDNF, producing additive cholinergic and neuroplasticity effects that may exceed either herb used alone. Combining Centella asiatica with vitamin C and zinc in wound-healing formulations is mechanistically supported, as asiaticoside-driven collagen synthesis requires ascorbate as a cofactor for prolyl hydroxylase and zinc for MMP regulation, enhancing dermal repair outcomes. For antioxidant applications, co-supplementation with alpha-lipoic acid or coenzyme Q10 may complement Centella's upregulation of SOD and catalase by providing additional mitochondrial membrane-level ROS quenching, though direct clinical evidence for these specific combinations in humans is not yet established.

Safety & Interactions

Centella asiatica is generally regarded as safe at conventional supplemental and food-grade doses, with an established OTC use history; however, three documented cases of hepatotoxicity have been reported in the medical literature—including granulomatous hepatitis, chronic active hepatitis, and hepatic necrosis—all resolving upon discontinuation, necessitating caution in individuals with pre-existing liver disease or concurrent hepatotoxic drug use. Common side effects at higher doses include gastrointestinal upset (nausea, abdominal discomfort) and, in sensitive individuals, contact dermatitis with topical preparations; formal systematic safety data across diverse populations remain limited. Drug interaction data are largely absent from the published literature; theoretical interactions exist with sedative medications (additive CNS depression), hepatotoxic drugs (additive liver stress), and potentially with APOE4-genotype-dependent pharmacogenomics that have not been characterized. Centella asiatica is not recommended during pregnancy or lactation due to insufficient safety data, and individuals with a personal or family history of liver disease, those on immunosuppressants, or anticoagulant therapy should consult a healthcare provider before use; doses exceeding 1,000 mg/day of standardized extract should be medically supervised.